Literature DB >> 21186050

The clock gene Per2 is required for normal platelet formation and function.

Yue Zhao1, Ying Zhang, Shiming Wang, Zichun Hua, Jianfa Zhang.   

Abstract

INTRODUCTION: Apoptotic cell death is a highly regulated genetic program, which has been observed in mature megakaryocytes fragmenting into platelets. The clock gene Per2, a key component of core clock oscillator, was involved in affecting both cell cycle control and apoptosis. Thus, loss of Per2 function may be considered potential influence of platelet formation and function.
METHODS: Per2-null mice and C57BL/6 mice were used in the study. Bleeding time, platelet count, megakaryocyte count, megakaryocyte ploidy, megakaryocyte apoptosis, rate of proplatelet formation, clot retraction, platelet aggregation and secretion were performed to evaluate thrombopoiesis and hemostasis. Quantitative RT-PCR was employed to analyze genes expression in liver, bone marrow and enriched megakaryocytes.
RESULTS: The Per2-null mice had nearly 50% platelet counts in peripheral blood. Per2-null platelets were compromised in their ability to aggregate and secretion, consistent with a marked reduction in the number of dense and a-granules. Megakaryocytes from Per2-null mice showed no significant variation in number but increased in ploidy. Ultrastructural examination of Per2-null megakaryocytes revealed many vacuoles in demarcation membranes and reduction in platelet granules. Megakaryocytes from Per2-null bone marrow decreased the rate of proplatelet formation and impaired apoptosis. Per2-null mice showed increased both in Tpo in livers and its receptors C-mpl in bone marrow, and the megakaryocytes from these mice decreased P53 expression, consequently increased Bcl-xl and Bcl-2 level.
CONCLUSIONS: The clock gene Per2 modulating the apoptosis of megakaryocytes was required for platelet formation and function. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21186050     DOI: 10.1016/j.thromres.2010.11.025

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

Review 1.  Complexities in cardiovascular rhythmicity: perspectives on circadian normality, ageing and disease.

Authors:  Oliver Monfredi; Edward G Lakatta
Journal:  Cardiovasc Res       Date:  2019-09-01       Impact factor: 10.787

2.  Proposed megakaryocytic regulon of p53: the genes engaged to control cell cycle and apoptosis during megakaryocytic differentiation.

Authors:  Pani A Apostolidis; Stephan Lindsey; William M Miller; Eleftherios T Papoutsakis
Journal:  Physiol Genomics       Date:  2012-05-01       Impact factor: 3.107

3.  Loss of the clock protein PER2 shortens the erythrocyte life span in mice.

Authors:  Qi Sun; Yue Zhao; Yunxia Yang; Xiao Yang; Minghui Li; Xi Xu; Dan Wen; Junsong Wang; Jianfa Zhang
Journal:  J Biol Chem       Date:  2017-06-12       Impact factor: 5.157

4.  Role of tumor suppressor p53 in megakaryopoiesis and platelet function.

Authors:  Pani A Apostolidis; Donna S Woulfe; Massiel Chavez; William M Miller; Eleftherios T Papoutsakis
Journal:  Exp Hematol       Date:  2011-10-21       Impact factor: 3.084

5.  The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors.

Authors:  Frank A J L Scheer; Alan D Michelson; Andrew L Frelinger; Heather Evoniuk; Erin E Kelly; Mary McCarthy; Lauren A Doamekpor; Marc R Barnard; Steven A Shea
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

6.  Intense light as anticoagulant therapy in humans.

Authors:  Yoshimasa Oyama; Sydney Shuff; Pavel Davizon-Castillo; Nathan Clendenen; Tobias Eckle
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

Review 7.  Targeting circadian PER2 as therapy in myocardial ischemia and reperfusion injury.

Authors:  Yoshimasa Oyama; Lori A Walker; Tobias Eckle
Journal:  Chronobiol Int       Date:  2021-05-25       Impact factor: 3.749

8.  Period2 downregulation inhibits glioma cell apoptosis by activating the MDM2-TP53 pathway.

Authors:  Niu Zhanfeng; Wang Chengquan; Xia Hechun; Wang Jun; Zhang Lijian; Ma Dede; Liu Wenbin; Yin Lei
Journal:  Oncotarget       Date:  2016-05-10

Review 9.  Chronobiological Influence Over Cardiovascular Function: The Good, the Bad, and the Ugly.

Authors:  Samir Rana; Sumanth D Prabhu; Martin E Young
Journal:  Circ Res       Date:  2020-01-16       Impact factor: 17.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.